Readout AI
Readout.ai provides AI tools for analyzing preclinical and clinical trial data, automatically.
Readout AI
Readout.ai provides AI tools for analyzing preclinical and clinical trial data, automatically.
TL;DR
What they do: AI platform that automates analysis, statistics, tables/figures, and written reporting for preclinical and clinical trial data
Stage: Pre-seed / early-stage
Funding (total): 1,670,000 USD
Founders / leadership: Matthew Michelson, PhD (CEO); Michael Shleifer, PhD (co-founder)
Team size (reported): 3 employees
Company Overview
Problem Domain
Clinical trials and preclinical trial data analysis and reporting
Industry
Health / Clinical Trials / Life Sciences
Funding Track Record
1,670,000 USD
Round included participation from Mucker Capital, Necessary Ventures, and angel investor Ryan Fukushima
Investor Signal
“Led by Meridian Street Capital with participation from Mucker Capital, Necessary Ventures, and angel Ryan Fukushima”